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siRNAAutophagy is an important cellular process by which ATG5 initiates the formation of double membrane
vesicles (DMVs). Upon infection, DMVs have been shown to harbor the replicase complex of positive-strand
RNA viruses such as MHV, poliovirus, and equine arteritis virus. Recently, it has been shown that autophagy
proteins are proviral factors that favor initiation of hepatitis C virus (HCV) infection. Here, we identiﬁed
ATG5 as an interacting protein for the HCV NS5B. ATG5/NS5B interaction was conﬁrmed by co-IP and
metabolic labeling studies. Furthermore, ATG5 protein colocalizes with NS4B, a constituent of the
membranous web. Importantly, immunoﬂuorescence staining demonstrated a strong colocalization of
ATG5 and NS5B within perinuclear regions of infected cells at 2 days postinfection. However, colocalization
was completely lacking at 5 DPI, suggesting that HCV utilizes ATG5 as a proviral factor during the onset of
viral infection. Finally, inhibition of autophagy through ATG5 silencing blocks HCV replication.phagy-related gene 5; DMV,
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There is compelling evidence that replication of all positive-
stranded RNA viruses requires the formation of virus-induced
membrane vesicles and that DMVs are the sites of genome replication
for some positive-stranded RNA viruses such as PV, MHV, EAV, dengue
virus, coronavirus, and coxsackievirus (Gosert et al., 2002; Lee et al.,
2008; Pedersen et al., 1999; Schlegel et al., 1996; Suhy et al., 2000;
Wong et al., 2008). In cells, DMVs derived from the endoplasmic
reticulum membranes can be produced through the ubiquitous
autophagy pathways (Klionsky and Emr, 2000). Autophagy, which
has been well characterized in yeast, is an essential process by which
bulk protein degradation and organelle turnover take place (Kim and
Klionsky, 2000; Mizushima et al., 1998).
In response to a limited supply of amino acids due to environ-
mental depletion, the autophagy process will generate a new pool of
amino acids required for cellular homeostasis. Recently, the contri-
bution of an autophagy protein, ATG5, to viral replication has beendemonstrated (Prentice et al., 2004). Indeed, production of MHV
particles is profoundly reduced (N99%) in ATG5−/− knockout (KO)
embryonic stem cells (Prentice et al., 2004). In this system, the
expression of ATG5 in ATG5−/− cells restores virus production. The
relationship between ATG5 and MHV replication may come from the
ability of ATG5 to initiate the formation of DMVs, which have been
observed in MHV-infected cells (Gosert et al., 2002; Mizushima et al.,
2001). As seen for dengue virus-2 (DV2), when autophagy is blocked
by ATG5-KOMEF cells, extracellular DV2 virus titers are reduced by 3-
fold compared to those from wild-type MEF cells (Lee et al., 2008).
Altered vesicles, called the membranous web, have been observed
in cells harboring HCV replicons (Egger et al., 2002; Gosert et al.,
2003). Because HCV replicons replicate autonomously in Huh-7, it has
been proposed that the membranous web that contain the HCV
replication complexes represents the genuine site of viral replication
(Gosert et al., 2003; Moradpour et al., 2003). In HCV-infected cells,
accumulation of lipid droplets, shown to be essential for HCV
replication, has been observed in the proximity of the membranous
web (Miyanari et al., 2007). Given the involvement of autophagy at
the site of replication of other positive-stranded RNA viruses, are the
autophagy proteins or structure involved in HCV replication? In that
regard, Tanida et al. (2009) recently showed that Atg7 silencing
decreased the levels of infectious HCVcc by about 40%, whereas
intracellular HCV RNA and protein levels remained unchanged. At the
same time, another group demonstrated that autophagy proteins
(ATG4b and Beclin-1) are required only for the initiation of incoming
HCV RNA translation/replication (Dreux et al., 2009).
Fig. 2. Speciﬁc interaction of HCV NS5BΔ21 protein with ATG5 as observed by co-IP.
A. Soluble yeast extracts containingNS5BΔ21 (N-terminal c-myc tag) andATG5(N-terminal
HA tag) were incubated with different monoclonal antibodies and the immunoprecipitates
were pulled downusing proteinA/Gbeads. Precipitated proteinswere revealed byWestern
blot using anti-c-myc (left panel) or anti-HA (right panel)monoclonal antibodies. Note that
IP of ATG5 using anti-HAmonoclonal antibody coprecipitated NS5BΔ21 (lane 2). Anti-HCV
NS5A (lane 1) or no antibody (beads only, lane 3) did not precipitate NS5BΔ21. Soluble
extract loadedon thegelwasusedas the sizemarker forNS5BΔ21. IP ofNS5BΔ21usinganti-
c-mycantibodyprecipitatedATG5(lane5)butnot anti-HCVNS5Aantibody (lane6). Soluble
extract loaded on the gelwas used as the sizemarker for ATG5 (lane 7). B. Soluble [35S]Met-
labeledproteinextractwas immunoprecipitatedusinganti-HA(lanes1 and2)or anti-c-myc
(lanes 3 and 4). Extracts were incubated in the presence (lanes 1 and 3) or absence (lanes 2
and 4) of cupric sulfate, which induced NS5BΔ21 expression. Precipitated bands were
analyzed by SDS–PAGE followed by autoradiography.
2 Rapid CommunicationTo identify novel cellular factors that may play an essential role in
HCV RNA replication, we have previously screened a human liver
cDNA library for proteins interacting with the HCV NS5B RNA-
dependent RNA polymerase (RdRp). Here we report that ATG5, a
protein required for the formation of DMV in embryonic stem cell
(Mizushima et al., 2001), speciﬁcally interacts with HCV NS5B. We
propose that the NS5B/ATG5 interaction may be required for the
initial onset of HCV replication.
Results
ATG5 interacts speciﬁcally with HCV NS5B protein
Using HCV NS5BΔ21 protein as a bait in the yeast two-hybrid
system, we identiﬁed positive clones from a human liver library. The
clones that showed the strongest blue color (MEL 1 gene activation)
on SD (−Leu, −Trp, −His, −Ade/+X α-gal) plates were chosen for
further characterization. Two of these positive clones matched the
sequence of the human eukaryotic initiation factor 4AII (eIF4AII),
recently identiﬁed as an interacting protein for HCV NS5B (Kyono
et al., 2002). Two more clones corresponded to the EMBL/GenBank/
DDBJ accession number Y711588a. This gene is highly homologous to
the Saccharomyces cerevisiae ATG5 gene (Hammond et al., 1998).
ATG5/NS5B interaction was conﬁrmed in the yeast two-hybrid
system using the full-length human ATG5 gene ampliﬁed from a
human liver cDNA library (Clontech) (Fig. 1). As a control, a panel of
proteins (RAR-β, RAR-α, HCV core, and nonstructural protein: NS3prot,
NS3hel, NS4A, and NS4B) cloned in the GAL4 DNA binding domain was
tested for interaction with ATG5. From this panel, only HCV NS3prot
protein gave a weak signal, but the interaction was not characterized
further (data not shown).
To demonstrate a physical interaction between ATG5 and NS5B
proteins, we performed co-IP on radio-inert or metabolically labeled
yeast cells coexpressing ATG5 and NS5B. We used yeast cells in this
study because cotransfection of Huh-7 cells with c-myc-NS5B and HA-
tagged ATG5 resulted in a low level expression of ATG5 protein. Yeast
extracts were immunoprecipitated with monoclonal antibody against
either the c-myc or theHA tag, followed by separation on SDS–PAGE. As
shown in Fig. 2A, an immunoreactive band (lane 2) that corresponds to
the sizeof theNS5Bprotein (68 kDa; lane4)was coimmunoprecipitated
with ATG5. This band was not present when the extracts were
immunoprecipitated with monoclonal anti-5A antibody (lane 1) or
without any antibody (ProteinA/G sepharosebeads alone) (lane 3). The
bands corresponding to the 50- and 25-kDa molecular weight are the
heavy and light chains, respectively, of the antibody. Conversely, ATG5
was coimmunoprecipitated with NS5B when the same extract was
incubated with monoclonal anti-c-myc antibody. Indeed, a distinct
immunoreactive band (lane 5) that corresponds to the size of ATG5Fig. 1. The NS5BΔ21 protein interacts with the full-length human ATG5 in yeast two-
hybrid assay. NS5B and ATG5 fused to the Gal4 DNA binding and activation domains,
respectively, were double-transformed into AH109 cells. Four independent colonies of
recombinant AH109 cells were allowed to grow for a few days on−Leu,−Trp SDmedium
(left panel), afterwhich theywere replica-plated onto−Leu,−Trp,−His,−Ade+X-αgal
plates (right panel).(lane 7) was detected. However, this band could not be immunopre-
cipitated by the monoclonal anti-5A antibody (lane 6). This protein–
protein interaction was further substantiated by the metabolic labeling
experiments shown in Fig. 2B in which ATG5 was constitutively
expressed and NS5B expression was under a copper-inducible promot-
er. As expected, when the labeled extracts were immunoprecipitated
with monoclonal anti-HA, a prominent band corresponding to the size
of ATG5 was detected in yeast extracts under induced (lane 1) and
noninduced (lane 2) conditions. However, the band corresponding to
NS5B was only detected in lane 1 (induced condition). When the same
extracts were immunoprecipitated with monoclonal anti-c-myc anti-
body, an intense band corresponding to the size of NS5B was apparent
under the induced condition (lane 3). As expected, a band corre-
sponding to the size of ATG5was also detected in the extracts under the
induced condition (lane 3) but not under the noninduced condition
(lane 4). Taken together, these observations indicate that ATG5 and
NS5B interact.
To map the interaction domains between NS5B and ATG5, N- and
C-terminally truncated mutants of both proteins were assessed by a
yeast two-hybrid system. For that purpose, the truncated fragments
were inserted into a pGBKT7 or pGADT7 plasmid. As illustrated in
Fig. 3, all constructs containing the C-terminal end of the NS5B
displayed interaction with ATG5, while truncation of the NS5B C-
terminus completely abrogated such interaction. To conﬁrm the data
obtained by yeast two-hybrid screening, co-IP of the putative
Fig. 3.Mapping of the NS5BΔ21 and ATG5 binding domains. Results are indicated in the column on the right and were obtained by yeast two-hybrid assay (ﬁrst two columns) or by
co-IP (third column). Deletion mutants of NS5B were assessed for interaction with full-length ATG5. The binding area covered the N-terminal amino acids 450–570 as indicated by
yeast two-hybrid assay and co-IP. Note that none of the deletion mutants of NS5BΔ21 self-activated in the yeast two-hybrid screen, as shown in the second column. nd indicates not
done.
3Rapid Communicationinteracting domains was performed. Both techniques were able to
identify the C-terminal end (aa 450–570) of NS5B as the interacting
domain for ATG5 (Fig. 3). The NS5B may have several amino acids
involved in this interaction since the fragments 1–501, 500–535, and
536–570 independently interacted with ATG5. Thus, the binding
domain of NS5B to ATG5 corresponds to the back surface of the thumb
domain which has been proposed to be a premium site for protein-
protein interaction due to the presence of a highly conserved patch of
basic amino acids (Bressanelli et al., 1999).Fig. 4. A. Huh7 and C5B cells were grown for 48 h and costained with antibodies speciﬁc to A
areas (a) are indicated by rectangles. Notice the colocalization of NS4B with ATG5 in C5B ce
GFP-ATG5. Proteins were resolved on SDS–PAGE and visualized byWestern blot using a polyc
M/M, microsome and mitochondria.ATG5 is localized to the membranous web
The interaction observed between ATG5 and the HCV NS5B RdRp
suggests that ATG5 might be involved in HCV replication. In cells
replicating HCV RNA, NS5B has been localized to the membranous web
(Egger et al., 2002; Gosert et al., 2003). Therefore, we analyzed the
localization of ATG5 and NS4B (a well-recognized marker of the
membranous web) in genome-length C5B replicon cells (Aligo et al.,
2009; Konan et al., 2003). The results presented in Fig. 4A indicate thatTG5 and NS4B protein. All samples were examined via confocal microscopy. Magniﬁed
lls. B. Subcellular fractionation of clone A cells (subgenomic replicon) transfected with
lonal rabbit anti-NS5B (left) or a monoclonal anti-GFP (right). N, nucleus; C, cytoplasm;
4 Rapid CommunicationNS4B indeed colocalizedwith the endogenousATG5protein. It is known
that ATG5 and its conjugated form, ATG5-APG12, are mostly cytoplas-
mic in mouse embryonic stem cells but that their association with the
membrane increases upon starvation (Mizushima et al., 2001). Thus, we
looked at the subcellular membrane association of ATG5 in replicon
cells. As expected, bothNS5BandATG5proteinswere excluded from the
cytoplasmic fraction (Fig. 4B). Indeed, both proteins appeared to reside
in the microsomal/mitochondrial fractions, suggesting that ATG5 is
directed to membranes in replicon cells. Note that the nuclear fractions
contain both proteins most likely through contamination from the
single-step puriﬁcation protocol of the nuclear fraction.
ATG5 transiently interacts with NS5B during HCV infection
Previously, we and others have unsuccessfully attempted to
identify a HCV protein involved in the modulation of the autophagic
response that occurs upon HCV infection (Ait-Goughoulte et al., 2008;
Dreux et al., 2009). It has recently been suggested that autophagy is
required only early in infection (Dreux et al., 2009). Therefore, we
evaluated the colocalization of ATG5 and NS5B in infected Huh7 cells
at 2 days postinfection (2 DPI). The selection of 2 DPI, as our earliest
time point, was based on the slow replication of JFH1 in Huh7 cells for
the ﬁrst few days of infection (Wakita et al., 2005; Zhong et al., 2005).
Indeed, at 1 DPI, HCV core, NS5B, and NS5A were undetectable by
immunoﬂuorescence staining (data not shown). Therefore, infected
Huh7 cells were transfected with pEGFP-ATG5 and analyzed at 2 orFig. 5. A. Subcellular distribution of NS5B and ATG5 in HCVcc-infected cells. JFH1-infected Hu
Colocalization of ATG5 and NS5B was observed at 2 DPI (magniﬁed area in b) but not at 5 D
cells were transfected with siRNA targeting ATG5 or with a scramble siRNA as control. The c
Western blot. As expected, scramble siRNA had no effect on HCV replication, whereas ATG5
from samples in panel B. Mock, mock-infected cells.5 DPI for the presence of NS5B and ATG5 (Fig. 5A). To our surprise, a
strong colocalization of GFP-ATG5 and NS5B was evident in approx-
imately 80% of infected cells at 2 DPI, but completely disappeared at
5 DPI. This result suggests that ATG5–NS5B interaction occurs only
during the initial onset of HCV replication and may explain why this
interaction has not been detected previously.
ATG5 silencing inhibits HCV replication
ATG5 silencing is known to disrupt autophagy (Matsushita et al.,
2007; Mizushima et al., 2001). Thus, we used ATG5 siRNA to evaluate
the importance of ATG5–NS5B interaction on HCV replication. As
controls, a scramble siRNA was used. The results indicate that
silencing ATG5 up to 2 DPI results in undetectable HCV core protein
(Fig. 5B) and in a marked reduction in intracellular viral replication as
observed by qRT–PCR (Fig. 5C). This results suggest that ATG5 is
required for proper viral replication and this requirement is likely
through ATG5–NS5B interaction.
Discussion
Recent reports suggest a role for autophagic proteins in HCV
replication and/or secretion (Ait-Goughoulte et al., 2008; Dreux and
Chisari, 2009; Dreux et al., 2009; Tanida et al., 2009). However, these
reports are conﬂicting and no consensus has yet been reached. Here
we provide for the ﬁrst time a link between a HCV protein, NS5B, andh7 cells were transfected with the GFP-ATG5 DNA construct and analyzed at 2 or 5 DPI.
PI (magniﬁed area in c). B. Silencing ATG5 reduced viral replication in Huh7 cells. Huh7
ells were then infected for 2 days and analyzed for the presence of HCV core protein by
greatly reduced HCV protein expression. C. Quantiﬁcation of intracellular HCV genome
5Rapid Communicationthe autophagy machinery. The speciﬁc interaction observed between
ATG5 and NS5B was through the thumb domain of the polymerase, a
region with numerous basic amino acids that could favor protein–
protein interaction.
Using Huh7 cells harboring HCV replicon, we showed that ATG5 is
associated with the membrane and colocalizes with the membranous
web constituent, NS4B. We then used HCVcc to better deﬁne the
subcellular distribution of ATG5 and NS5B during the course of viral
replication. Interestingly, strong colocalization between the two
proteins was only seen early in infection and was completely absent
late in infection (Fig. 5A). This result may imply that the ATG5–NS5B
interaction is required for the onset of the viral replication. Since the
primary known function of ATG5 is the formation of the crescent
shape DMV, one could argue that HCV requires membrane import
during the early stages of viral infection. Indeed, ATG5 is involved in
other positive-strand RNA virus replication, probably through the
formation of DMV (Khakpoor et al., 2009; Lee et al., 2008; Prentice
et al., 2004). However, we were unsuccessful in visualizing these
crescent shaped vesicles or autophagosomes in HCV-infected cells.
Although unconjugated ATG5 can be found on the crescent-shaped
autophagosome precursor (Mizushima et al., 2001), maturation into
the autophagosome requires the conjugate ATG5–APG12 as well as a
series of speciﬁc interactions with autophagy proteins (George et al.,
2000; Kim et al., 2001; Mizushima et al., 2001). Because viruses such
as MHV and perhaps HCVmay utilize ATG5 to initiate DMV formation
but may not require further maturation of the DMV into autophago-
somes, the function of APG12 in virus-induced DMVs remains to be
determined.
Replicase proteins of positive-stranded RNA viruses are localized
in virus-induced membrane vesicles. In HCV replicon-harboring cells,
a membranous structure that contains both viral proteins and RNA,
called the membranous web, has been identiﬁed (Moradpour et al.,
2003). It has been shown that the formation of the membranous web
can be induced by NS4B alone (Konan et al., 2003). Another report has
shown physical interaction between NS5B (or NS5A) and the SNARE-
like protein, hVAP-33 (Tu et al., 1999), leading to the localization of
the HCV replicase complex on lipid rafts (Aizaki et al., 2006; Gao et al.,
2004). Despite these ﬁndings, the role of the host factors in the
formation and function of the HCV replication complex needs to be
better deﬁned. In that regard, we propose that autophagic proteins,
and perhaps the resulting membranes, are indispensable during the
onset of HCV replication.
Materials and methods
Yeast two-hybrid screening
Yeast strains for yeast two-hybrid screening were obtained from
Clontech (Mountain View, CA, USA) as components of the pretrans-
formed MATCHMAKER cDNA libraries and the MATCHMAKER Two-
Hybrid System 3. S. cerevisiae Y187 (MATα), which contained the
pretransformed human cDNA library (complexity N2–4×106 inde-
pendent clones) cloned into the Gal4 activation domain vector
(pACT2) was allowed to mate with S. cerevisiae AH109 (MATa),
which had been transformed with a Gal4 DNA-binding domain vector
(pGBKT7) containing HCV NS5B as a bait. To construct the bait, the
HCV NS5B gene lacking the region encoding the C-terminal 21 amino
acid residues was ampliﬁed by PCR using the HCV-BK (genotype 1b)
genomic cDNA as a template and NS5B-H1 and NS5B-R1700 as
primers (Table S1). The resulting NS5BΔ21 gene containing unique
EcoRI and BamHI sites at the N- and C-termini, respectively, was
cloned into the pGBKT7 expression plasmid to generate an in-frame
fusion protein with a Gal4 DNA binding domain. The resulting
plasmid, pGBKT7-5BΔ21 was sequenced and subsequently used to
transform the AH109 yeast strain. Following mating, the diploid yeast
strain (Y187-AH109-NS5B) was selected on SD medium in theabsence of leucine, tryptophan, and histidine (−LTH). Eight hundred
potential positive yeast clones were obtained from two million
screenable clones and were replica-plated onto X-α Gal indicator
plates in the absence of leucine, tryptophan, histidine, and adenine.
Three hundred blue colonies (positive for X-α Gal as a result of MEL1
gene activation) were selected by prototrophy for histidine and
adenine. These clones were retested for positive interaction, and
pACT2/cDNA plasmids were isolated from 20 strong positive clones as
reﬂected by the intensity of the blue color formed on X-α Gal
indicator plates. These plasmids were retransformed into yeast strains
carrying the bait construct, pGBKT7-5BΔ21 or pGBKT7, to conﬁrm
true interactions. Clones that gave a positive signal when cotrans-
formed with pGBKT7-5BΔ21 were chosen for DNA sequencing. The
DNA sequences of the positive pACT2/cDNA clones were translated
and compared with a nonredundant sequence database using the
BLAST program through the National Center for Biotechnology
Information network service. CLUSTAL_X program was used to
analyze statistically signiﬁcant matches.
Full-length hAPG5–NS5BΔ21 interaction by yeast two-hybrid assay
To obtain the full-length coding region of the hATG5 gene
(825 bp), the primers ATG5-H1 and ATG5-R800 (Table S1) were
prepared for PCR ampliﬁcation using a human liver cDNA library
(Clontech) as a template. PCR products with uniqueNdeI and BamHI at
the N- and C-termini, respectively, were cloned into the pGADT7
vector. The sequence of the resulting plasmid was conﬁrmed by DNA
sequencing. The integrity of the hATG5 and NS5BΔ21 genes inserted
into the yeast plasmids (pGBKT7 and pGADT7) was conﬁrmed in vitro
by expressing the two proteins using the TNT® T7 Coupled
Reticulocite Lysate System (Promega, Madison, WI, USA) as described
by the manufacturer. Final conﬁrmation of hAPG5/NS5BΔ21 interac-
tions by yeast two-hybrid experiments in AH109 cells was carried out
as described previously.
Coimmunoprecipitation (Co-IP)
For co-IP, N-terminal tag HA-hAPG5 and c-myc-NS5BΔ21 proteins
were expressed in the BJ2168 yeast strain. Brieﬂy, the hAPG5 and
NS5BΔ21 genes were ampliﬁed using the Tag-HA/APG5-R800-Trp
and Tag-MYC/NS5B-R1700-Leu primer sets, respectively (Table S1).
The PCR products were then cloned into the YEpc (NS5B) and YEpTDH
(hAPG5) plasmids using unique restriction sites (Table S1). The
resulting expression plasmids, YEpc-NS5BΔ21 (copper-inducible) and
YEpTDH-hAPG5, were used to transform a protease-deﬁcient yeast
strain (BJ2168). The double transformant yeast strain, YEpc-
NS5BΔ21/YEpTDH-hAPG5 was grown in SD medium depleted of
tryptophan and leucine (−LT). For the induction of c-myc-NS5BΔ21,
cupric sulfate (1 μM) was added to the −LT medium and incubated
overnight at 30 °C.
Yeast extracts containing soluble hAPG5 and NS5BΔ21 proteins
were prepared according to the protocol of Mizushima et al. (2001).
Brieﬂy, yeast cells were washed and resuspended in ice-cold TES
buffer (50 mM Tris, 5 mM EDTA, and 150 mMNaCl, pH 7.5). Yeast cell
walls were disrupted with acid-washed glass beads by vortexing
vigorously for 10 minutes. After centrifugation at 3000×g for
5 minutes, the supernatant (cytoplasmic and microsomal fractions)
wasmixedwith 0.1 volume of 10% NP40 and incubated for 15 minutes
before centrifugation at 10,000×g for 15 minutes. Aliquots of the
resulting supernatant (500–600 μg of protein) were incubatedwith or
without 1 μl of monoclonal anti-Myc antibody (9E10: Santa Cruz, CA,
USA) or anti-HA antibody (F6: Santa Cruz) for 2 hours. A protein A/G
sepharose bead mixture (Pierce, Rockford, IL, USA) (10 μl) was added,
and samples were incubated for an additional 2 hours. The sepharose
beads were washed three times with TES buffer, and the bound
proteins were eluted with 30 μl of Laemmli buffer. Samples (20 μl)
6 Rapid Communicationwere analyzed by SDS–PAGE and immunoblotting. Proteins were
detected by monoclonal anti-c-Myc (9E10) or anti-HA (F2) and
visualized by enhanced chemiluminescence (ECL; Amersham Phar-
macia Biotech; Baie d'Urfé, QC, Canada).
Alternatively, co-IP was performed usingmetabolically labeled cell
extract. In brief, BJ2168 yeast cells carrying the YEpc-NS5BΔ21 and
YEpTDH-hAPG5 plasmids were grown in SD (−LT)medium overnight
at 30 °C. When the cells reached mid-log phase, they were washed
and incubated for 1 hour in SD (−LT) medium depleted in
methionine. Subsequently, 10 μM of cupric sulfate and 35S-labeled
methionine (50 μCi) were added to the culture, and incubated for
3 hours. After washing the cells twice with SD medium, yeast extracts
were prepared for co-IP study as described previously. Immunopre-
cipitated proteins were separated on SDS–PAGE followed by autora-
diography. The negative control included yeast extracts prepared
from the yeast strain without cupric sulfate induction (i.e., expressing
only HA-hAPG5) and subjected to the same analysis.
Mapping of hAPG5–NS5BΔ21 interaction domain
Deletion mutants of NS5BΔ21 were generated by PCR using the
primers indicated in Table S1. PCR fragments were inserted in pGBKT7
or pGADT7 and the interactions were analyzed by yeast two-hybrid
assay. To identify the interaction domains, we performed co-IP of the
deletion mutants expressed in the BJ2168 yeast strain using the YEpc
and YEpTDH plasmids.
Preparation of viral stock and infection
JFH-1 virus was generated in Huh7 cells by transfection of in vitro-
transcribed full-length JFH1 RNA (MEGAscript, Ambion, Streetville,
Ontario, Canada), and viral stocks were produced by infection of Huh7
cells at a multiplicity of infection (MOI) of 0.01, as described previously
(Guevin et al., 2009).
Subcellular fractionation analysis
For subcellular fractionation, the hAPG5 gene was cloned into the
pEGFP-C1 plasmid (Clontech). The resulting pEGFP-hAPG5 plasmid
was then transfected into Clone-A and naïve Huh7 cells using
Lipofectamine as suggested by the manufacturer (Invitrogen; Bur-
lington, Ontario, Canada). The engineering and characterization of the
clone-A cells, which constitutively expressed the HCV nonstructural
proteins (NS3, 4A, 4B, 5A, and 5B), have been reported elsewhere
(Howe et al., 2006). At 48 hours after transfection, cells were
trypsinized and washed twice with PBS. After washing, 2×107 cells
were homogenized in a hypotonic buffer containing 10 mM Tris–HCl,
pH 7.5, and 2 mM MgCl2, followed by centrifugation at 1000×g for
5 min to yield the nuclear fraction. The supernatant was then
centrifuged at 14,000×g for 40 min to pellet the microsomal/
mitochondrial (mit/mic) fraction. The nuclear and the mit/mic
pellets were resuspended in the same volume as the ﬁnal supernatant
using the hypotonic buffer, and 20 μl of each extract was resolved on
SDS–PAGE and immunoblotting using either a rabbit polyclonal
antiserum directed against the HCV NS5BΔ21 or a mouse monoclonal
anti-GFP (GFP-20; Sigma). Proteins were visualized by enhanced
chemiluminescence (ECL; Amersham Pharmacia Biotech).
Indirect immunoﬂuorescence
For indirect immunoﬂuorescence, cells were transfected with the
pEGFP-hATG5 and infected with HCVcc JFH1 at a MOI of 0.01. At
24 hours after transfection, the cells were trypsinized and grown on
glass coverslips for another 24 hours. The coverslips were then ﬁxed
in PBS containing 4% formaldehyde for 10 min, washed three times in
PBS, and incubated for 1 h at 4 °C in blocking buffer (PBS, 3% bovineserum albumin, 0.1% Triton X-100). After three washes in PBS, the
coverslips were incubated with a rabbit polyclonal antibody directed
against the HCV NS5B protein (generously provided by Dr Takaji
Wakita, National Institute of Infectious Diseases, Tokyo, Japan)
(dilution 1:200) in blocking buffer for 1 hour at room temperature
(RT). The coverslips were then washed three times in PBS and
incubated for 1 hour at RT with Alexa Fluor 488 or 568-conjugated
secondary antibody goat anti-mouse or anti-rabbit IgG (Jackson
ImmunoResearch Laboratories Inc., West Grove, PA, USA) (dilution
1:500). Coverslips were washed four times in PBS and mounted on
glass slides with Prolong™ Antifade (Molecular Probes), and cells
were examined with a laser scanning confocal BioRad Radiance 2000
microscope.
SiRNA transfection
SiRNA duplexes targeting human were purchased from Ambion
(siRNA ATG5 no. AM16708A and scramble siRNA no. 4611G). SiRNA
duplexes (150 pmol) were transfected into 1×105 Huh7 cells using
the RNAiMAX transfection reagent (Invitrogen) and infected 6 hours
later with HCV JFH-1. Protein knockdown was usually analyzed
48 hours after transfection.
Western blot analysis
Cells were washed three times in phosphate-buffered saline and
lysed in RIPA buffer (50 mm Tris–HCl, pH 8.0, 1% (vol./vol.) Nonidet
P40, 0.5% sodium deoxycholate, 150 mm NaCl and 0.1% (vol./vol.)
SDS) with a Complete Protease Inhibitor Mixture (Roche Applied
Science). After SDS–PAGE electrophoresis, protein samples were
transferred to an Immuno-Blot PVDF membrane for protein blotting
(Bio-Rad) for 45 min. Nonspeciﬁc binding sites were blocked for
1 hour in PBS–5% skimmed milk, and the membrane was stained for
1 hour with the primary antibodies. The antibodies used were HCV
polyclonal anti-core (obtained fromDr Denis Leclerc, Laval University,
Canada) (dilution 1:1000) and anti-ATG5 (FL-275) polyclonal
antibody (Santa Cruz Biotechnology, CA, USA) (dilution 1:1000).
After incubating with the primary antibody, the membranes were
washed four times in PBS–0.1% Tween-20. Bound antibodies were
detected by incubation for 45 min with a goat anti-rabbit HRP
antibody (Jackson ImmunoResearch) (dilution 1:10,000). The signals
were developed with SuperSignal™ West Pico chemiluminescent
substrate (Pierce).
Quantitative RT–PCR
Total cellular RNA was prepared from siRNA-transfected cells by
using the RNeasy Mini Kit (QIAGEN). The cDNA were prepared from
250 ng of total cellular RNA. Brieﬂy, RNAs were incubated 3 min at
70 °C then cooled on ice for 2 min before the addition of 4 μl of RT-
Buffer 5X (Invitrogen), 2 μl of DTT (0.1 M), 1 μl of random primer p
(dN6) (100 ng/μl), 1 μl of dNTP (20 mM), 20 U of RNAsin, and 100 U
of MMLV reverse transcriptase. Samples were incubated for 10 min at
25 °C and 1 h at 37 °C. To inactivate the MMLV, samples were
incubated 15 min at 70 °C, and cDNAs were diluted to a ﬁnal volume
of 200 μl with Rnase-free water. Primers used for ampliﬁcation were
5′UTR-R: 5′-GAGTGGGTTTA TCCAAGAAAG-3′ and 5′UTR-F: 5′-
TCTGCGGAACCGGTGAGT-3′. The mixture consists of 2.5 μl of cDNA
in a ﬁnal volume of 25 μl of the reactionmixture containing 8.6 μl H2O,
0.5 μl of probe FAM-UTR (12.5 μM) CCGGAATTGCCGGGAAGACTG, and
0.25 μl (90 μM) of each HCV primers. For the internal control, the 18S
Ribosomal RNA Kit was used as suggested by the manufacturer
(Applied Biosystem). The mixture was completed with 12.5 μl of the
TaqMan Universal Master Mix 2X (Applied Biosystem), and the
ampliﬁcation was performed as suggested by the manufacturer in a
Rotor-Gene RG-3000 (Corbet Research).
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